TITLE

Clinical digest. Most people treated for schizophrenia experience no lasting improvements in health

PUB. DATE
April 2012
SOURCE
Nursing Standard;4/18/2012, Vol. 26 Issue 33, p14
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article discusses research which was published in the article "Sustained Favourable Long-Term Outcome in the Treatment of Schizophrenia: A 3-Year Prospective Observational Study" by G Cuyun Carter et al. and found that most people treated for schizophrenia experience no lasting improvements in health.
ACCESSION #
74494589

 

Related Articles

  • Subtrochanteric and Diaphyseal Femur Fractures in Patients Treated With Alendronate: A Register-Based National Cohort Study. Abrahamsen, Bo; Eiken, Pia; Eastell, Richard // Journal of Bone & Mineral Research;Jun2009, Vol. 24 Issue 6, p1095 

    The article reports on the results of research which was conducted in an effort to determine whether the use of the bisphosphonate alendronate in the treatment of fracture could lead to the development of additional atypical femur fractures. Researchers found that a high number of patients that...

  • Retreatment With Teriparatide One Year After the First Teriparatide Course in Patients on Continued Long-Term Alendronate. Cosman, Felicia; Nieves, Jeri W.; Zion, Marsha; Barbuto, Nancy; Lindsay, Robert // Journal of Bone & Mineral Research;Jun2009, Vol. 24 Issue 6, p1110 

    The article reports on the results of research which was conducted to determine whether a second retreatment course with teriparatide could produce similar biochemical and bone miineral density changes that were seen seen during a previous treatment in people who had been treated previously with...

  • Balancing hope with safety. Folkenberg, Judy // FDA Consumer;Jun90, Vol. 24 Issue 5, p16 

    Reports how Clozaril, a new antipsychotic drug, can help thousands of the most seriously afflicted schizophrenics function well enough to leave mental hospitals. But it also can cause a serious blood disorder. INSET: A psychiatric mystery, by J.F..

  • Treatment resistance in schizophrenia. Johnston, Eve C.; Sandler, Robert // BMJ: British Medical Journal (International Edition);2/10/96, Vol. 312 Issue 7027, p325 

    Focuses on the use of alternative drugs in treating schizophrenia. Functions of chlorpromazine; Use of functional imaging techniques in schizophrenia.

  • Cognitive improvement is possible for schizophrenic patients. Spaulding, William D. // Behavioral Health Treatment;Oct96, Vol. 1 Issue 4, p3 

    Asserts that cognitive improvement is possible for schizophrenic patients in the United States. Results of re-examination of old assumptions concerning schizophrenia; Clinical manifestations of the ailment; Advances in neuropsychology.

  • Early relapse may result from neuroleptic withdrawal.  // Behavioral Health Treatment;Jun97, Vol. 2 Issue 6, p5 

    States that persons with schizophrenia who are abruptly withdrawn from neuroleptics may be twice as likely to suffer relapses within six months. Information on the study which provided the evidence; Details on the findings of the study.

  • Fish oil may relieve schizophrenia symptoms.  // Behavioral Health Treatment;Oct97, Vol. 2 Issue 10, p3 

    Presents information on a study which examined ways to reduce the symptoms associated with schizophrenia. Information on fish oil and how it can be used as a treatment for certain schizophrenic symptoms; Identification of countries in which research is being carried out; Details on side effects...

  • Healing without hurting the troubled mind. Bradley, David // New Scientist;9/12/92, Vol. 135 Issue 1838, p18 

    Reveals that a drug candidate that could treat the symptoms of schizophrenia without causing the debilitating side-effects of traditional drugs has been developed by chemists in the United States. Compound is named HP 236; Could replace the drug clozapine; Background of the disorder.

  • Schizophrenia. Paltak, Margie // FDA Consumer;Sep/Oct97, Vol. 31 Issue 6, p23 

    Scrutinizes schizophrenia, a mental illness. Causes and symptoms of schizophrenia; Characteristics of a schizophrenic; Development of antipsychotic medications and their side effects; Other treatment for schizophrenia.

  • APA practice guideline for the treatment of patients with... Rose, Verna L. // American Family Physician;9/15/1997, Vol. 56 Issue 4, p1217 

    Provides guidelines for the treatment of patients with schizophrenia issued by the American Psychiatric Association (APA). Eight main sections of the guideline; List of conventional antipsychotic drugs in the guideline; Coverage and features of the guideline.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics